Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pia Protti

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
BMC Immunology|December 7, 2005
Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptidesMonica Moro, Virginia Cecconi, Chiara Martinoli, et al.
Blood|October 24, 2002
Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3Giuseppe Consogno, Simona Manici, Valeria Facchinetti, et al.
International Journal of Molecular Sciences|August 10, 2024
Anakinra-Loaded Sphingomyelin Nanosystems Modulate In Vitro IL-1-Dependent Pro-Tumor Inflammation in Pancreatic CancerMarcelina Abal-Sanisidro, Michele De Luca, Stefania Roma, et al.
Molecular Immunology|December 13, 2005
Immunogenic and structural properties of the Asn-Gly-Arg (NGR) tumor neovasculature-homing motifPaola Di Matteo, Flavio Curnis, Renato Longhi, et al.
European Journal of Immunology|March 23, 2010
The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptidesVirginia Cecconi, Monica Moro, Sara Del Mare, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patientsElena Tassi, Francesca Gavazzi, Luca Albarello, et al.
The Journal of Experimental Medicine|February 23, 2011
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancerLucia De Monte, Michele Reni, Elena Tassi, et al.
Journal of Proteome Research|January 9, 2008
Serological immunoreactivity against colon cancer proteome varies upon disease progressionLucia De Monte, Francesca Sanvito, Stefano Olivieri, et al.
Oncoimmunology|July 9, 2015
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survivalGiulia Di Lullo, Magda Marcatti, Silvia Heltai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
IFN-gamma produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesionsSamantha Seresini, Massimo Origoni, Flavia Lillo, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
BMC Immunology|December 7, 2005
Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptidesMonica Moro, Virginia Cecconi, Chiara Martinoli, et al.
Blood|October 24, 2002
Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3Giuseppe Consogno, Simona Manici, Valeria Facchinetti, et al.
International Journal of Molecular Sciences|August 10, 2024
Anakinra-Loaded Sphingomyelin Nanosystems Modulate In Vitro IL-1-Dependent Pro-Tumor Inflammation in Pancreatic CancerMarcelina Abal-Sanisidro, Michele De Luca, Stefania Roma, et al.
Molecular Immunology|December 13, 2005
Immunogenic and structural properties of the Asn-Gly-Arg (NGR) tumor neovasculature-homing motifPaola Di Matteo, Flavio Curnis, Renato Longhi, et al.
European Journal of Immunology|March 23, 2010
The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptidesVirginia Cecconi, Monica Moro, Sara Del Mare, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patientsElena Tassi, Francesca Gavazzi, Luca Albarello, et al.
The Journal of Experimental Medicine|February 23, 2011
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancerLucia De Monte, Michele Reni, Elena Tassi, et al.
Journal of Proteome Research|January 9, 2008
Serological immunoreactivity against colon cancer proteome varies upon disease progressionLucia De Monte, Francesca Sanvito, Stefano Olivieri, et al.
Oncoimmunology|July 9, 2015
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survivalGiulia Di Lullo, Magda Marcatti, Silvia Heltai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
IFN-gamma produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesionsSamantha Seresini, Massimo Origoni, Flavia Lillo, et al.
Pageof 5